Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dilated Cardiomyopathy Detection Using Artificial Intelligence and Screening With Mobile Technology

NCT06688396 is registered in ClinicalTrials.gov with Lancaster General Hospital as lead sponsor.

NCT NCT06688396
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06688396 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dilated Cardiomyopathy Detection Using Artificial Intelligence and Screening With Mobile Technology
Lead sponsor
Lancaster General Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
December 4, 2024
Completion date
December 31, 2026
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dilated cardiomyopathy, heart disease, heart failure